Themis Medicare Limited has filed a disclosure with BSE Limited and the National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in connection with its proposed preferential allotment of convertible warrants. The disclosure was made on 12th May, 2026, and was signed by Dr. Dinesh Patel, Chairman (DIN: 00033273).

Background and Regulatory Context

The process for the preferential allotment of convertible warrants was initiated following approval by the Board of Directors at its meeting held on 13th February, 2026. Subsequent to the board approval, the company had submitted an application to both BSE Limited and the National Stock Exchange of India Limited seeking in-principle approval for the preferential allotment.

Following the submission of the application, the stock exchanges raised certain queries and observations. In response, and in compliance with the provisions of the Articles of Association of the Company, Themis Medicare took the necessary steps to address these regulatory requirements.

Documents Submitted

The company obtained and submitted two key documents as part of its compliance obligations. The following table summarises the documents filed:

Both documents have been duly updated and hosted on the official website of the company at www.themismedicare.com . The Valuation Report and the revised Compliance Certificate are accessible through the statutory documents section of the website.

Compliance and Disclosure

The disclosure has been made in strict compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Themis Medicare has requested both exchanges to take the intimation on record. The company's registered office is located at Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi, Gujarat, and its corporate office is situated at 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104.

Themis Medicare Limited has announced the opening of a special window for shareholders to address pending share transfer requests and facilitate dematerialization of physical securities. This initiative follows regulatory guidelines established by the Securities and Exchange Board of India (SEBI) and aims to help investors regularize their shareholding status.

Special Window Details

The company has opened a one-year special window from February 05, 2026 to February 04, 2027, pursuant to SEBI Circular No. HD/38/13/11(2)2026-MIRSDPOD/1/3750/2026 dated January 30, 2026. This facility specifically targets shareholders who had transactions prior to April 01, 2019 but faced challenges in completing the transfer process.

Eligibility Criteria

The special window is available to shareholders of Themis Medicare Limited who meet specific conditions. The company has provided a detailed eligibility matrix to clarify qualification requirements:

Process Requirements and Restrictions

Shareholders seeking to utilize this special window must submit original share certificates along with transfer deeds and supporting documents. The company emphasizes that only requests accompanied by complete documentation will be considered under this facility.

Shares successfully transferred through this window will be mandatorily credited to the transferee in dematerialized (Demat) mode only. Additionally, these shares will be subject to a lock-in period of one year from the date of registration of transfer, during which they cannot be transferred, lien marked, or pledged.

Contact Information and Resources

Shareholders interested in availing this special window facility can contact the company's Registrar & Transfer Agent, MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited). The RTA is located at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai-400083.

The complete SEBI Circular is available on the company's website at https://www.themismedicare.com/investor-relations/investornews for detailed reference. The company encourages all eligible investors to initiate necessary actions without delay to regularize their pending transfer cases during this special window period.